Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein

Respiratory syncytial virus (RSV) is the leading cause of severe respiratory disease in infants and children and represents an important global health burden for the elderly and the immunocompromised. Despite decades of research efforts, no licensed vaccine for RSV is available. We have developed vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cimica, Velasco, Boigard, Hélène, Bhatia, Bipin, Fallon, John T., Alimova, Alexandra, Gottlieb, Paul, Galarza, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895010/
https://www.ncbi.nlm.nih.gov/pubmed/27030590
http://dx.doi.org/10.1128/CVI.00720-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895010/
https://www.ncbi.nlm.nih.gov/pubmed/27030590
http://dx.doi.org/10.1128/CVI.00720-15

Ejemplares similares